drugset / Trial / NCT04987320
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)
RandomizedParallel-groupOpen-labelBasic science
Summary
The main objective of this study is to evaluate the pharmacokinetics (PK) of a single dose of Olpasiran in Chinese participants with elevated serum lipoprotein(a) (Lp\[a\]).
Timeline
- Start
- 2021-07-28
- Primary completion
- 2021-11-12
- Completion
- 2022-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olpasiran | Unknown | — | Subcutaneous |